Orange Book product · Brand (NDA)
EDECRIN
ETHACRYNIC ACID
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
ETHACRYNIC ACID
Strength
25MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 016092
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2020ETHACRYNIC ACIDGeneric (ANDA)
ANDA 213240 · CHARTWELL RX
- 2020ETHACRYNIC ACIDGeneric (ANDA)
ANDA 212417 · UPSHER SMITH LABS
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211719 · LUPIN
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211232 · SCIEGEN PHARMS
- 2019ETHACRYNIC ACIDGeneric (ANDA)
ANDA 211809 · AGNITIO
- 2018ETHACRYNIC ACIDGeneric (ANDA)
ANDA 205709 · ALVOGEN
- 2018ETHACRYNIC ACIDGeneric (ANDA)
ANDA 208805 · AMNEAL PHARMS CO
- 2017ETHACRYNIC ACIDGeneric (ANDA)
ANDA 208501 · PH HEALTH
- 2017ETHACRYNIC ACIDGeneric (ANDA)
ANDA 207262 · HIKMA
- 2016ETHACRYNIC ACIDGeneric (ANDA)
ANDA 205609 · ADAPTIS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
